| Literature DB >> 20562059 |
C Marquardt1, E Matuschek, E Bölke, P A Gerber, M Peiper, J V Seydlitz-Kurzbach, B A Buhren, M van Griensven, W Budach, M Hassan, G Kukova, R Mota, D Höfer, K Orth, W Fleischmann.
Abstract
BACKGROUND: Antiseptics are frequently used for the prophylaxis and treatment of local infections of chronic wounds. Whereas local antiseptics in general have a positive effect on wound healing an uncritical use may impair wound healing due to toxic side effects.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20562059 PMCID: PMC3352009 DOI: 10.1186/2047-783x-15-5-204
Source DB: PubMed Journal: Eur J Med Res ISSN: 0949-2321 Impact factor: 2.175
Figure 1Stereoscopic view on the CAM after 5 minutes application of 72% isopropanol (Cutasept™). Please note diffuse haemorrhage reactions of CAM vessels.
Figure 2View on the CAM after short term application of 0.1% octenidin-2HCl F (Octenisept™, 5 minutes), which resulted in severe lysis of vessels.
Figure 3Stereoscopic view on the CAM after long term application of 10% PVP-I solution (Betaisodona™, 60 minutes). The severe haemorrhages are clearly visible.
Figure 5View on the lysed vessels after 60 minutes application of 0.1% polyhexanid plus 0.1% undecyleneamidopropyl - betain (Prontosan™).
Figure 43% lysosomal PVP-I ointment (Repithel™, 60 minutes). Please note the moderate irritation of the vessels on the CAM by Repithel™ ointment only in the area of application.
Irritation scores (IS), their standard deviation (STD) and irritation thresholds (IT) of antiseptics
| Product‰ | Substance | IS MV (STD) | IS Lit. 15, 16 | IT | |
|---|---|---|---|---|---|
| Rinsing solutions | 0,9% physiological saline, Ringer solution | 0.0 | (0.0) | ||
| Buffered solution | Phosphate-buffered saline | 0.0 | (0.0) | ||
| 1% SDS | Sodium dodecyl sulfat | 16.9 | (1.5) | ||
| Dettol™ 1 : 14 | 0.35% chloroxylenol + 0.8% denaturated alcohol | 17.4 | (0.0) | 1 : 500 | |
| cutasept™ | 72% isopropanol | 18.2 | (0.8) | 18.0 | 1 : 200 |
| Octenisept™ | 0.1% octenidin-2HCl | 14.8 | (5.1) | 14.0 | 1 : 100 |
| Betaisodona™ | 10% PVP-I | 5.3 | (1.6) | 1 : 10 | |
| Betaisodona™ 1:10 | 1% PVP-I | 1.3 | (0.8) | 2.0 | |
| Prontosan™ | 0.1% polyhexanid | 1.6 | (2.7) | ||
| Lavanid™ | 0.04% polyhexanid | 0.0 | (0.0) | 0.0 | |
| MDT | sterile washings from Lucilia sericata maggots | 0.0 | (0.0) | ||
| Iruxol-n™ | Enzyme filtrations from Clostridium histolyticum | 0.0 | (0.0) | ||
| Flammazine™ | 1% silver-sulfadiazine | 1.3 | (2.2) | ||
| Betaisodona™ | 10% PVP-I | 15.8 | (2.1) | ||
| Repithel™ | 3% lysosomal PVP-I | 4.8 | (2.1) | ||
| Iodosorb™ ointment | 1,8% cadexomer-iodine | 8.3 | (3.5) | ||
| Iodosorb™ pellets | 1% cadexomer-iodine | 5.7 | (3.5) | ||
IS Lit. = irritation scores of former studies.
Angioirritative potential of antiseptics in long term application
| Product™ | Substance | Reaction | Time [min] |
|---|---|---|---|
| Rinsing solutions | 0,9% physiological saline, Ringer solution | no | 60 |
| Buffered solution | PBS | no | 60 |
| 1% SDS | Sodium dodecyl sulfat | severe | 5 |
| Dettol™ | 0.35% chloroxylenol + 0.8% denaturated alcohol | severe | 5 |
| Cutasept™ | 72% isopropanol | severe | 5 |
| Octenisept™ | 0.1% octenidin - 2HCL | severe | 5 |
| Betaisodona™ | 10% PVP-I | severe | 60 |
| Betaisodona™ 1:10 | 1% PVP-I | severe | 60 |
| Prontosan™ | 0.1% polyhexanid | severe | 60 |
| Lavanid™ | 0.04% polyhexanid | no | 60 |
| MDT | sterile washings from Lucilia sericata maggots | no | 60 |
| Iruxol-n™ | Enzyme filtrations from Clostridium histolyticum | no | 5 |
| Flammazine™ | 1% silver-sulfadiazine | slight | 5 |
| Betaisodona™ ointment | 10% PVP-I | severe | 5 |
| Repithel™ | 3% lysosomal PVP-I | moderate | 60 |
| Iodosorb™ | 1,8% cadexomer-iodine | moderate | 60 |
| Iodosorb™ Pellets | 1% cadexomer-iodine | moderate | 60 |